Home
Storia in 1 fonti
Five biotech news updates to stay on top of today
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
Raccontata da
statnews.com
Timeline cronologica
- ·
Pharmalittle: We're reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a Phase 1 clinical trial
- ·
Five biotech news updates to stay on top of today
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
- ·
Ahead of ASCO, all eyes on pancreatic cancer
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
- ·
Allogene CEO David Chang stepping down
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout